Concord Biotech acquires Celliimune to accelerate DNA-engineered cancer therapies
Rs 66 lakh acquisition will support DNA engineering and novel cell-gene therapy alternatives to conventional chemotherapy
Rs 66 lakh acquisition will support DNA engineering and novel cell-gene therapy alternatives to conventional chemotherapy
The inspection was conducted from July 22-25, 2025
This achievement underscores our unwavering commitment to upholding the highest standards of quality, safety, and regulatory compliance
J B Chemicals and Pharmaceuticals receives ANDA approval for Amitriptyline Hydrochloride Tablets from USFDA
These observations are procedural in nature and none of them are related to data integrity
The inspection was successfully completed
Shelter Pharma Limited secured an order from Berlin International Medical Co D3Cure 50 ml x 30000 pcs
The inspection at Unit 1 by the USFDA has been successfully completed, with no observations under Form 483
The said Unit complies with the prescribed Good Manufacturing practices as per relevant WHO technical Report Series
Eris Lifesciences enters into term loan agreement with Citi Bank
Subscribe To Our Newsletter & Stay Updated